Mintzer JE - Search Results

1

Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic Influences.

Peters ME, Vaidya V, Drye LT, Devanand DP, Mintzer JE, Pollock BG, Porsteinsson AP, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, Avramopoulos D; CitAD Research Group. Peters ME, et al. Among authors: mintzer je. J Geriatr Psychiatry Neurol. 2016 Mar;29(2):59-64. doi: 10.1177/0891988715601735. Epub 2015 Aug 23. J Geriatr Psychiatry Neurol. 2016. PMID: 26303700 Free PMC article. Clinical Trial.

2

Treatment of agitation in patients with dementia.

Mintzer JE, Hoernig KS, Mirski DF. Mintzer JE, et al. Clin Geriatr Med. 1998 Feb;14(1):147-75. Clin Geriatr Med. 1998. PMID: 9456340 Review.

3

Fenfluramine challenge test as a marker of serotonin activity in patients with Alzheimer's dementia and agitation.

Mintzer J, Brawman-Mintzer O, Mirski DF, Unger R, Nietert P, Meeks A, Sampson R. Mintzer J, et al. Biol Psychiatry. 1998 Nov 1;44(9):918-21. doi: 10.1016/s0006-3223(98)00004-3. Biol Psychiatry. 1998. PMID: 9807649

4

A 24-week randomized trial of controlled-release physostigmine in patients with Alzheimer's disease.

Thal LJ, Ferguson JM, Mintzer J, Raskin A, Targum SD. Thal LJ, et al. Neurology. 1999 Apr 12;52(6):1146-52. doi: 10.1212/wnl.52.6.1146. Neurology. 1999. PMID: 10214735 Clinical Trial.

5

Underlying mechanisms of psychosis and aggression in patients with Alzheimer's disease.

Mintzer JE. Mintzer JE. J Clin Psychiatry. 2001;62 Suppl 21:23-5. J Clin Psychiatry. 2001. PMID: 11584984 Review.

6

Olanzapine in the treatment of anxiety symptoms due to Alzheimer's disease: a post hoc analysis.

Mintzer J, Faison W, Street JS, Sutton VK, Breier A. Mintzer J, et al. Int J Geriatr Psychiatry. 2001 Dec;16 Suppl 1:S71-7. doi: 10.1002/1099-1166(200112)16:1+<::aid-gps568>3.0.co;2-m. Int J Geriatr Psychiatry. 2001. PMID: 11748790 Clinical Trial.

7

The efficacy of galantamine in the treatment of Alzheimer's disease: comparison of patients previously treated with acetylcholinesterase inhibitors to patients with no prior exposure.

Mintzer JE, Kershaw P. Mintzer JE, et al. Int J Geriatr Psychiatry. 2003 Apr;18(4):292-7. doi: 10.1002/gps.826. Int J Geriatr Psychiatry. 2003. PMID: 12673604 Clinical Trial.

8

The search for better noncholinergic treatment options for Alzheimer's disease.

Mintzer JE. Mintzer JE. J Clin Psychiatry. 2003;64 Suppl 9:18-22. J Clin Psychiatry. 2003. PMID: 12934970 Review.

9

A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil.

Finkel SI, Mintzer JE, Dysken M, Krishnan KR, Burt T, McRae T. Finkel SI, et al. Among authors: mintzer je. Int J Geriatr Psychiatry. 2004 Jan;19(1):9-18. doi: 10.1002/gps.998. Int J Geriatr Psychiatry. 2004. PMID: 14716694 Clinical Trial.

10

Clinical application of operationalized criteria for 'Depression of Alzheimer's Disease'.

Rosenberg PB, Onyike CU, Katz IR, Porsteinsson AP, Mintzer JE, Schneider LS, Rabins PV, Meinert CL, Martin BK, Lyketsos CG; Depression of Alzheimer's Disease Study. Rosenberg PB, et al. Among authors: mintzer je. Int J Geriatr Psychiatry. 2005 Feb;20(2):119-27. doi: 10.1002/gps.1261. Int J Geriatr Psychiatry. 2005. PMID: 15660424

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters